SQURPHARMA Statistics

Total Valuation

Square Pharmaceuticals PLC. has a market cap or net worth of BDT 199.10 billion. The enterprise value is 142.93 billion.

Market Cap	199.10B
Enterprise Value	142.93B

Important Dates

The next estimated earnings date is Wednesday, October 23, 2024.

Earnings Date	Oct 23, 2024
Ex-Dividend Date	n/a

Share Statistics

Square Pharmaceuticals PLC. has 886.45 million shares outstanding.

Shares Outstanding	886.45M
Shares Change (YoY)	n/a
Shares Change (QoQ)	+0.11%
Owned by Insiders (%)	35.18%
Owned by Institutions (%)	4.32%
Float	574.64M

Valuation Ratios

The trailing PE ratio is 9.84 and the forward PE ratio is 9.47.

PE Ratio	9.84
Forward PE	9.47
PS Ratio	2.89
PB Ratio	1.63
P/FCF Ratio	19.26
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 6.20, with an EV/FCF ratio of 13.82.

EV / Earnings	7.06
EV / Sales	2.08
EV / EBITDA	6.20
EV / EBIT	7.06
EV / FCF	13.82

Financial Position

The company has a current ratio of 14.39, with a Debt / Equity ratio of 0.01.

Current Ratio	14.39
Quick Ratio	11.19
Debt / Equity	0.01
Debt / EBITDA	0.08
Debt / FCF	0.15
Interest Coverage	82.28

Financial Efficiency

Return on equity (ROE) is 17.52% and return on invested capital (ROIC) is 9.41%.

Return on Equity (ROE)	17.52%
Return on Assets (ROA)	8.99%
Return on Capital (ROIC)	9.41%
Revenue Per Employee	5.50M
Profits Per Employee	1.62M
Employee Count	12,503
Asset Turnover	0.56
Inventory Turnover	2.93

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +6.95% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	+6.95%
50-Day Moving Average	228.80
200-Day Moving Average	216.51
Relative Strength Index (RSI)	40.62
Average Volume (20 Days)	318,150

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Square Pharmaceuticals PLC. had revenue of BDT 68.81 billion and earned 20.24 billion in profits. Earnings per share was 22.83.

Revenue	68.81B
Gross Profit	33.21B
Operating Income	17.66B
Pretax Income	24.40B
Net Income	20.24B
EBITDA	20.46B
EBIT	17.66B
Earnings Per Share (EPS)	22.83

Full Income Statement

Balance Sheet

The company has 48.40 billion in cash and 1.55 billion in debt, giving a net cash position of 56.17 billion or 63.37 per share.

Cash & Cash Equivalents	48.40B
Total Debt	1.55B
Net Cash	56.17B
Net Cash Per Share	63.37
Equity (Book Value)	121.79B
Book Value Per Share	137.39
Working Capital	63.33B

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 14.19 billion and capital expenditures -3.85 billion, giving a free cash flow of 10.34 billion.

Operating Cash Flow	14.19B
Capital Expenditures	-3.85B
Free Cash Flow	10.34B
FCF Per Share	11.66

Full Cash Flow Statement

Margins

Gross margin is 48.27%, with operating and profit margins of 25.67% and 29.41%.

Gross Margin	48.27%
Operating Margin	25.67%
Pretax Margin	35.46%
Profit Margin	29.41%
EBITDA Margin	29.74%
EBIT Margin	25.67%
FCF Margin	15.03%

Dividends & Yields

This stock pays an annual dividend of 10.50, which amounts to a dividend yield of 4.67%.

Dividend Per Share	10.50
Dividend Yield	4.67%
Dividend Growth (YoY)	5.00%
Years of Dividend Growth	6
Payout Ratio	45.63%
Buyback Yield	n/a
Shareholder Yield	4.67%
Earnings Yield	10.17%
FCF Yield	5.19%

Dividend Details

Stock Splits

The last stock split was on November 23, 2020. It was a forward split with a ratio of 1.05.

Last Split Date	Nov 23, 2020
Split Type	Forward
Split Ratio	1.05

Scores

Square Pharmaceuticals PLC. has an Altman Z-Score of 20.38.

Altman Z-Score	20.38
Piotroski F-Score	n/a